Argan is a holding company. The company conducts operations through its subsidiaries: Gemma Power Systems, LLC, which is an engineering, procurement and construction contractor; Atlantic Projects Company Limited, which provides turbine, boiler and rotating equipment installation, commissioning and outage services; The Roberts Company, Inc., which provides on-site services that support maintenance, shutdowns and emergency mobilizations for industrial plants in the southern region of the U.S.; and Southern Maryland Cable, Inc., which conducts business as SMC Infrastructure Solutions, and provides technology wiring and utility construction solutions to customers in the mid-Atlantic region of the U.S.
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's drug candidates in active development consist of: CAP-1002 (allogeneic cardiosphere-derived cells (CDCs)), which is for the treatment of DMD, advanced heart failure and myocardial infarction; and CAP-2003 (CDC extracellular vesicles, including exosomes), which is for the treatment of inflammatory conditions. CAP-2003 is in pre-clinical development.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.